Moving from viral suppression to comprehensive patient-centered care: The high prevalence of comorbid conditions and health risk factors in HIV-1-infected patients in Australia

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 2, 2012, Pages 109-114

  Broom, Jennifer ^a,b   Sowden, David ^b   Williams, Merran ^c   Taing, Kuong ^c   Morwood, Karen ^c   McGill, Karen ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NAMBOUR GENERAL HOSPITAL   (Australia)

^c Clinic 87   (Australia)

Author keywords

chronic disease; highly active antiretroviral therapy; human immunodeficiency virus; prevention

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; AUSTRALIA; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGRESSIVE PATIENT CARE; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TREATMENT FAILURE;

ADULT; ANXIETY; CD4 LYMPHOCYTE COUNT; COMORBIDITY; COMPREHENSIVE HEALTH CARE; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; HYPERGLYCEMIA; HYPERTENSION; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; PREVALENCE; PROTEINURIA; QUEENSLAND; RETROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84859352199     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711418832     Document Type: Article

References (27)

1. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 1527; 24(10):1527-1535.
2. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371-383. (Pubitemid 47206603)
3. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132(5):369-372. (Pubitemid 30127775)
4. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006;24(9):1383-1388. (Pubitemid 46622002)
5. Calza L, Manfredi R, Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother. 2004;53(1):10-14. (Pubitemid 38072177)
6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-2512. (Pubitemid 47037350)
7. Monsuez JJ, Goujon C, Wyplosz B, Couzigou C, Escaut L, Vittecoq D. Cerebrovascular diseases in HIV-infected patients. Curr HIV Res. 2009;7(5):475-480.
8. Mijch A, Burgess P, Judd F, et al. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders. HIV Med. 2006;7(4):205-212.
9. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243-1250.
10. Gao S, Gui XE, Deng L, et al. Antiretroviral therapy hepatotoxicity: prevalence, risk factors, and clinical characteristics in a cohort of Han Chinese. Hepatol. 40(3):287-294.
11. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol. 2008;29(3):136-147.
12. Tomazic J, Ul K, Volcansek G, et al. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population. Wien Klin Wochenschr. 2007;119(21-22):639-646. (Pubitemid 350239502)
13. Kourtis AP, Bansil P, Kahn HS, Posner SF, Jamieson DJ. Diabetes trends in hospitalized HIV-infected persons in the United States, 1994-2004. Curr HIV Res. 2009;7(5):481-486.
14. Rodriguez-Novoa S, Alvarez E, Labarga P, Soriano V. Renal toxicity associated with tenofovir use. Expert Opin Drug Saf. 2010; 9(4):545-559.
15. Rachakonda AK, Kimmel PL. CKD in HIV-infected patients other than HIV-associated nephropathy. Adv Chronic Kidney Dis. 2010;17(1):83-93.
16. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis. 2007;11(11):1190-1195. (Pubitemid 350146299)
17. Luetkemeyer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007; 175(7):737-742. (Pubitemid 46536491)
18. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177(10):1164-1170. (Pubitemid 351717577)
19. Briganti EM, Branley P, Chadban SJ, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian diabetes, obesity and lifestyle study. Am J Kidney Dis. 2002;40(4):704-712.
20. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med. 2007;22(6):749-754. (Pubitemid 46763967)
21. Briganti EM, Shaw JE, Chadban SJ, et al. Untreated hypertension amongAustralian adults: the 1999-2000Australian diabetes, obesity and lifestyle study (AusDiab). Med J Aust. 2003;179(3):135-139. (Pubitemid 37025189)
22. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342-350.
23. SzczechLA,Menezes P,ByrdQuinlivanE, van der HorstC, Bartlett JA, SvetkeyLP.Microalbuminuria predicts overt proteinuria among patients with HIV infection. HIV Med. 2010;11(7):419-426.
24. Hall AM, Edwards SG, Lapsley M, et al. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009;54(6):1034-1042.
25. Coaccioli S, Del Giorno R, Crapa G, et al. Study of bone metabolism in patients with chronic HIV infection. Clin Ter. 2009; 160(6):451-456.
26. Yin MT, Shane E. Low bone-mineral density in patients with HIV: pathogenesis and clinical significance. Curr Opin Endocrinol Diabetes. 2006;13(6):497-502. (Pubitemid 44691254)
27. Clay PG, Voss LE, Williams C, Daume EC. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann Pharmacother. 2008;42(5):670-679. (Pubitemid 351619938)